Oncimmune Holdings PLC Enters Administration
Oncimmune Holdings PLC (AIM: ONC), an immunology company based in the UK specialising in precision medicine, entered administration on March 26, 2025. This occurred after the company was unable to find a buyer for its German trading subsidiary or secure additional capital to meet its short-term funding requirements, despite a comprehensive sale process and positive interest in the business.
Administrators Appointed: Simon Bonney and James Varney of Arafino Advisory have been appointed as joint administrators.
Advisors: White & Case and Pinsent Masons are providing advisory services to the company.
Registered Charges: Various IPF Partners have registered charges against the company.
On March 17, 2025, prior to the administration, Oncimmune Holdings PLC announced its intention to appoint administrators. Trading of the company’s shares has been suspended. This situation may have implications for hVIVO’s governance and could impact stakeholders’ perceptions of the company’s stability and leadership.
Debt Recovery Manual
Need help with a bad debt?